The US Bankruptcy Court gave an order approving the sale of certain assets of Generex Biotechnology Corporation on January 13, 2023. The debtor has been authorized to sell its certain assets to Terry Thompson, Richard Purcell, Dr. Jason Terrell, and Anthony Crisci, the Objecting Parties, for a purchase price of $1.55 million in cash. If a higher or better bid for the Equity or Claims is accepted and approved by the Bankruptcy Court, and the Trustee successfully closes on such better or higher bid, Trustee shall refund the Deposit to the Objecting Parties within seven days of closing with a successful bidder other than Objecting Parties.

The debtor?s assets include 64,153,151 common stock shares of Antigen Express, Inc. d/b/a NuGenerex Immuno Oncology, Inc. and 100% of the shares of Olaregen Therapeutix, Inc. that are owned by Debtor.